Skip to main content
ANAB logo

ANAB · Anaptysbio, Inc · Share Buybacks

Track ANAB — free
$46.63 -0.77 (-1.62%) At close · Nov 20
Market Cap
$1.39B
Shares
29.90M
Volume · Nov 20 432.48K Avg daily vol (3M) 494.29K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$100,000,000
as of 2026-06-30 · from Press release (reviewed)· through 2026-12-31
Remaining Authorization
$100,000,000
as of 2026-09-30
Program Utilization
-0.0% $0 used of $100,000,000
Program Announced Authorized Remaining Runs Through
2026-03-01 $100,000,000 $100,000,000 2026-12-31
— $175,000,000 $106,400,000 2026-03-31 expired

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it (on today's share basis). Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-03-31 YTD $0
2025-12-31 $68,626,000
2024-12-31 $456,000
2023-12-31 $50,000,000
2022-12-31 $0
2021-12-31 $0
2018-12-31 $0
2017-12-31 $0
2016-12-31 $1,000
2015-12-31 $0

Share counts and average prices are restated onto today's share basis across later stock splits; cash spent is as reported. ‡ marks a row kept as filed because a later split could not be attributed to this stock's shares.

Key facts CIK 1370053 CUSIP 032724106 13F (30d) 231 filings 212 filers Visit website Investor relations